FDA deputy commissioner system needs revision, McKenna & Cuneo partner Pilot advises.
This article was originally published in The Gray Sheet
Executive Summary
FDA DEPUTY COMMISSIONER STRUCTURE NEEDS REVISION, McKENNA & CUNEO PARTNER Larry Pilot maintained at a Washington Legal Foundation conference March 25 in Washington, D.C. Pilot declared that the replacement for former Commissioner Kessler should "take a good look at the organization. Analyze what personnel are doing in relation to the organization [and] in relation to the expectation of Congress. In particular, I would advise the commissioner to do away with this multiple deputy commissioner system."